Why We Ditched Cyanocobalamin for Methylcobalamin
Most energy drinks cut corners with cyanocobalamin—a cheap, synthetic form of B₁₂ your body has to convert before it can even use it. That conversion isn’t always efficient, and in the process your body is left with trace amounts of cyanide molecules to detoxify. It’s stable and inexpensive, which is why big brands lean on it—but cheap doesn’t mean good for you.
We chose methylcobalamin because it’s the active, natural form of B₁₂ already used by your nervous system and detox pathways. It skips the inefficient conversion step, supports methylation directly, and is better retained in the body over time. .
The Science Is Clear
Retention & Effectiveness: Even if absorption is similar, methylcobalamin stays in your system longer and is more available for the processes that matter—energy, methylation, and neural repair.
Natural vs. Synthetic: Methylcobalamin is bioidentical to the form found in food; cyanocobalamin is a man-made chemical that must be stripped down and rebuilt inside your body.
Genetic Advantage: Many people have genetic variations (like MTHFR) that make converting cyanocobalamin even less effective—methylcobalamin bypasses that completely.
Our Team’s Take
When the choice was put on the table, cost never entered the conversation. The decision to switch to methylcobalamin was an immediate yes—because giving you a vitamin that works with your body, not against it, is non-negotiable.
STUDIES REFERENCED
Hannibal, L., Axhemi, A., Glushchenko, A. V., Moreira, E. S., Brasch, N. E., & Jacobsen, D. W. (2016). Biochemistry and physiology of methylcobalamin. In R. Banerjee (Ed.), Handbook of Vitamin B12 (pp. 411–444). Wiley. https://doi.org/10.1002/9781118859685.ch21
Watanabe, F., Yabuta, Y., Tanioka, Y., & Bito, T. (2013). Vitamin B12-containing plant food sources for vegetarians. Nutrients, 5(12), 4976–4995. https://doi.org/10.3390/nu5124976
Yazaki, Y., Chowdhury, S. A., & Homma, I. (1990). Therapeutic effects of methylcobalamin on diabetic neuropathy. Clinical Therapeutics, 12(2), 161–170. https://doi.org/10.1016/0149-2918(90)90063-2